F Dx Advisors, Inc. West Pharmaceutical Services Inc Transaction History

F Dx Advisors, Inc.

$659 Million
Q1 2024

A detailed history of F Dx Advisors, Inc. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, F Dx Advisors, Inc. holds 2,499 shares of WST stock, worth $801,929. This represents 0.15% of its overall portfolio holdings.

Number of Shares

2,499

Previous 2,993 16.51%

Holding current value

$801,929

Previous $1.05 Million 6.17%

% of portfolio

0.15%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$338.27 - $413.0 $167,105 - $204,022	-494 Reduced 16.51%	2,499 $989,000
Q4 2023 Feb 12, 2024	SELL	$318.29 - $392.21 $155,643 - $191,790	-489 Reduced 14.04%	2,993 $1.05 Million
Q3 2023 Nov 02, 2023	SELL	$354.9 - $412.41 $347,802 - $404,161	-980 Reduced 21.96%	3,482 $1.31 Million
Q2 2023 Jul 17, 2023	BUY	$334.63 - $382.47 $425,649 - $486,501	1,272 Added 39.87%	4,462 $1.71 Million
Q4 2022 Feb 09, 2023	BUY	$209.34 - $261.61 $114,299 - $142,839	546 Added 20.65%	3,190 $751,000

Q3 2022 Nov 10, 2022	SELL	$246.08 - $343.65 $656,541 - $916,858	-2,668 Reduced 50.23%	2,644 $651,000
Q2 2022 Aug 03, 2022	SELL	$280.61 - $420.45 $137,218 - $205,600	-489 Reduced 8.43%	5,312 $1.61 Million
Q1 2022 May 03, 2022	SELL	$357.49 - $445.92 $472,601 - $589,506	-1,322 Reduced 18.56%	5,801 $2.38 Million
Q4 2021 Feb 01, 2022	SELL	$402.25 - $471.34 $130,731 - $153,185	-325 Reduced 4.36%	7,123 $3.34 Million
Q3 2021 Oct 08, 2021	BUY	$363.01 - $468.47 $230,874 - $297,946	636 Added 9.34%	7,448 $3.16 Million
Q2 2021 Aug 05, 2021	BUY	$284.77 - $363.2 $255,723 - $326,153	898 Added 15.18%	6,812 $2.45 Million
Q1 2021 Apr 14, 2021	BUY	$257.29 - $307.53 $1.09 Million - $1.31 Million	4,248 Added 254.98%	5,914 $1.67 Million
Q1 2021 Apr 13, 2021	SELL	$257.29 - $307.53 $941,166 - $1.12 Million	-3,658 Reduced 68.71%	1,666 $469,000
Q4 2020 Feb 08, 2021	BUY	$261.16 - $301.66 $281,269 - $324,887	1,077 Added 25.36%	5,324 $1.51 Million
Q3 2020 Nov 12, 2020	BUY	$224.99 - $288.02 $590,823 - $756,340	2,626 Added 162.0%	4,247 $1.17 Million
Q2 2020 Jul 22, 2020	SELL	$149.8 - $227.17 $54,227 - $82,235	-362 Reduced 18.26%	1,621 $368,000
Q1 2020 May 22, 2020	BUY	$128.96 - $174.76 $255,727 - $346,549	1,983 New	1,983 $302,000
Q1 2020 May 13, 2020	SELL	$128.96 - $174.76 $260,499 - $353,015	-2,020 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$137.6 - $151.21 $8,531 - $9,375	-62 Reduced 2.98%	2,020 $304,000
Q3 2019 Nov 07, 2019	SELL	$121.41 - $150.02 $785,158 - $970,179	-6,467 Reduced 75.65%	2,082 $295,000
Q2 2019 Jul 19, 2019	BUY	$111.27 - $125.15 $135,749 - $152,683	1,220 Added 16.65%	8,549 $1.07 Million
Q1 2019 May 14, 2019	BUY	$94.53 - $110.2 $454,216 - $529,511	4,805 Added 190.37%	7,329 $808,000
Q4 2018 Apr 29, 2019	SELL	$93.0 - $123.98 $456,630 - $608,741	-4,910 Reduced 66.05%	2,524 $247,000
Q4 2018 Feb 07, 2019	BUY	$93.0 - $123.98 $42,408 - $56,534	456 Added 6.53%	7,434 $729,000
Q3 2018 Nov 13, 2018	BUY	$98.01 - $123.47 $194,059 - $244,470	1,980 Added 39.62%	6,978 $862,000
Q2 2018 Aug 08, 2018	BUY	$83.32 - $101.88 $17,913 - $21,904	215 Added 4.5%	4,998 $496,000
Q1 2018 May 02, 2018	SELL	$85.56 - $102.4 $170,692 - $204,288	-1,995 Reduced 29.43%	4,783 $422,000
Q4 2017 Feb 09, 2018	SELL	$91.65 - $101.65 $29,877 - $33,137	-326 Reduced 4.59%	6,778 $669,000
Q3 2017 Nov 03, 2017	BUY	$84.54 - $96.75 $19,951 - $22,833	236 Added 3.44%	7,104 $684,000
Q2 2017 Aug 11, 2017	BUY	N/A	6,868	6,868 $649,000

Others Institutions Holding WST

# of Institutions

826

Shares Held

64.4M

Call Options Held

184K

Put Options Held

312K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $23.8B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account